STOX2 (storkhead box 2) is a transcriptional regulatory factor that functions as a DNA-binding transcription factor involved in placental and embryonic development 1. As a member of the storkhead box family, STOX2 acts as a master control gene regulating trophoblast differentiation pathways 2. The protein contains a highly conserved C-terminal domain critical for function, with alternative splicing patterns regulated by a long non-coding RNA within intron 3 2. STOX2 functions as a novel SMAD2/4 cofactor in TGF-β signaling within embryonic stem cells 3. Disease relevance: STOX2 is implicated in pre-eclampsia with fetal growth restriction, showing significantly lower expression in affected decidual tissue 4. The gene also plays critical roles in malignancy progression. In oral squamous cell carcinoma, STOX2 upregulation correlates with nodal metastasis and poor outcome, promoting cell growth, invasion, and chemotherapy resistance 1. In hydatidiform moles, miR-30a-mediated STOX2 downregulation activates ERK, AKT, and P38 signaling, driving excessive trophoblast proliferation 5. Additionally, STOX2 expression is regulated by lysyl-oxidase family genes in breast cancer, with LOX-dependent STOX2 upregulation promoting tumor progression 6.